E-clinical is a term used in a clinical study with reference to
electronic applications which are web-based tools employed to capture
live data from clinical trials for faster and better execution.
Additionally, e-clinical solutions aid efficient planning, tracking,
and execution of this data from different geographic areas.
Furthermore, they also improve relationships within departments such
as site coordinators of medical affairs and clinical investigators.
E-clinical solutions refer to a technology which helps accelerate the
process of clinical development and aggregate & standardize the
collected data for analysis at an individual patient level as well as
for cross trail views. The use of e-clinical solutions has simplified
the acquisition of analytics and clinical research data. Device &
drug tracking, integrated eCRF note changing, real-time
notifications, real-time reporting, and configurable report building
are a few important features of e-clinical solutions.
Request a Brochure of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25508
The global e-clinical solutions market is expected to expand
substantially due to the increasing operational costs &
regulatory requirements related to clinical research studies, the
rising acceptance of software solutions during clinical trials, and
the surge in R&D expenditure in pharmaceutical companies. In
addition, e-clinical solutions in Asia Pacific are on the rise owing
to the growing number of clinical trials especially across developing
countries. Developing markets including India, China, Korea, and
Taiwan have become good destinations for the outsourcing of clinical
trials due to the low service costs and presence of a large
population. However, concerns over patient data privacy and the lack
of skilled research professionals are hampering the implementation of
e-clinical solution. On the other hand, high operational costs
associated with e-clinical solutions are constraining the e-clinical
solutions market.
The e-clinical solutions market is segmented by product into the
following categories: clinical analytics platforms, Electronic Data
Capture (EDC), Clinical Data Management Systems (CDMS), safety
solutions, Randomization & Trial Supply Management (RTSM),
Electronic Clinical Outcome Assessment (ECOA), clinical data
integration platforms, Clinical Trial Management Systems (CTMS), and
electronic Trial Master File (eTMF). EDC and CDMS hold a large market
share, whereas ECOA is likely to witness a high growth rate during
the forecast period. On the basis of delivery mode, this market is
segregated into three groups: web-based, cloud-based solutions, and
on-premise. Furthermore, the market is divided based on clinical
trial phase into the following segments: phase I, phase II, phase
III, and phase IV. Finally, in terms of end-user application, the
market is classified into the following divisions: medical device
manufacturers, contract research organizations, hospitals, consulting
service companies, pharmaceutical & biotechnology industries, and
others.
Enquiry for discount on this report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=25508
Geographically, E-Clinical Solutions market is distributed over North
America, Europe, Latin America, Asia Pacific, and Middle East &
Africa. North America dominated this market because of the increasing
number of clinical trials conducted in the region, rising investment
in R&D resulting in the development of new products, growing
prevalence of lifestyle diseases, and increasing government support
for clinical trials. However, Asia Pacific is projected to grow at a
rapid rate during the forecast period on account of the increasing
number of R&D projects and the region’s developing economic
status.
Key players operating in this market include Parexel International
Corporation, Oracle Corporation, Merge Health Incorporated, Datatrak
International, Inc., BioClinica, CRF Health, ERT, E-Clinical
Solutions, OmniComm Systems Inc, and Medidata Solution, Inc. In order
to gain a competitive advantage in the industry, these players are
actively involved in organic and inorganic growth strategies.
Collaborations, partnerships, agreements, and new product launches
are some of the important strategies followed by them.
Request for TOC of the Report @
https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=25508
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment